CD248 deficiency promotes angiotensin II-induced aortic lesion by attenuating receptor stability in smooth muscle cells

IF 7.9 1区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL
Tai-Tzu Hsieh, Ya-Chu Ku, Chu-Jen Chen, Cheng-Hsiang Kuo, Bi-Ing Chang, Chien-Hung Yu, Yi-Heng Li, Pei-Jane Tsai, Shu-Wha Lin, Hua-Lin Wu, Chwan-Yau Luo, Yau-Sheng Tsai
{"title":"CD248 deficiency promotes angiotensin II-induced aortic lesion by attenuating receptor stability in smooth muscle cells","authors":"Tai-Tzu Hsieh,&nbsp;Ya-Chu Ku,&nbsp;Chu-Jen Chen,&nbsp;Cheng-Hsiang Kuo,&nbsp;Bi-Ing Chang,&nbsp;Chien-Hung Yu,&nbsp;Yi-Heng Li,&nbsp;Pei-Jane Tsai,&nbsp;Shu-Wha Lin,&nbsp;Hua-Lin Wu,&nbsp;Chwan-Yau Luo,&nbsp;Yau-Sheng Tsai","doi":"10.1002/ctm2.70352","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Abdominal aortic aneurysm (AAA) is characterized by progressive dilation of the abdominal aorta that has a high prevalence of death due to aortic rupture. The hallmark of AAA is severe degeneration of the aortic media with the loss of vascular smooth muscle cells (VSMCs), the main source of extracellular matrix (ECM) proteins. CD248 was originally implicated in angiogenesis and tumourigenesis, but its role in the development of AAA remains unclear.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Mice lacking CD248 (<i>Cd248</i><sup>−/−</sup>) were generated and evaluated for angiotensin II (Ang II) and high-cholesterol diet feeding induced AAA. Loss-of-function approaches in A7r5 and C3H10T1/2 cells were used to study the involvement of CD248 in the Ang II signalling.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>CD248 expression was upregulated in the media and adventitia of patients and mice with aortic aneurysm. CD248 deficiency in mice exacerbates Ang II-induced aortic lesion along with severe disruption of elastic fibres and the VSMC layer. Interestingly, while compensatory ECM deposition was found in the aortic lesion of <i>Cd248</i><sup>−/−</sup> mice, collagen I content and p38 activation were significantly attenuated. Silencing of CD248 in VSMCs downregulated mitogen-activated protein kinase activation and ECM production. Loss of CD248 in VSMCs destabilized the membrane receptors for Ang II and platelet-derived growth factor (PDGF), and the C-terminal cytoplasmic domain of CD248 is apparently involved in this interaction.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>The findings reveal that CD248 regulates the stability of the membrane receptors for Ang II and PDGF in VSMCs to transduce signals for collagen production in combating the loss of aortic wall strength during vascular remodelling.</p>\n </section>\n \n <section>\n \n <h3> Key points</h3>\n \n <div>\n <ul>\n \n <li>CD248 reduces the occurrence of angiotensin II (Ang II)-induced aortic lesion by facilitating collagen production to provide load-bearing properties to the aortic wall.</li>\n \n <li>CD248 regulates the stability of the membrane receptors for Ang II and PDGF in VSMCs.</li>\n \n <li>The C-terminal cytoplasmic tail of CD248 is a crucial domain that potentially regulates the stability of Ang II and PDGF receptors.</li>\n \n <li>This knowledge can enhance our understanding of how abdominal aortic aneurysm (AAA) can be treated through CD248-mediated signaling to maintain aortic wall strength during the remodeling process.</li>\n </ul>\n </div>\n </section>\n </div>","PeriodicalId":10189,"journal":{"name":"Clinical and Translational Medicine","volume":"15 5","pages":""},"PeriodicalIF":7.9000,"publicationDate":"2025-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ctm2.70352","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Translational Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ctm2.70352","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Abdominal aortic aneurysm (AAA) is characterized by progressive dilation of the abdominal aorta that has a high prevalence of death due to aortic rupture. The hallmark of AAA is severe degeneration of the aortic media with the loss of vascular smooth muscle cells (VSMCs), the main source of extracellular matrix (ECM) proteins. CD248 was originally implicated in angiogenesis and tumourigenesis, but its role in the development of AAA remains unclear.

Methods

Mice lacking CD248 (Cd248−/−) were generated and evaluated for angiotensin II (Ang II) and high-cholesterol diet feeding induced AAA. Loss-of-function approaches in A7r5 and C3H10T1/2 cells were used to study the involvement of CD248 in the Ang II signalling.

Results

CD248 expression was upregulated in the media and adventitia of patients and mice with aortic aneurysm. CD248 deficiency in mice exacerbates Ang II-induced aortic lesion along with severe disruption of elastic fibres and the VSMC layer. Interestingly, while compensatory ECM deposition was found in the aortic lesion of Cd248−/− mice, collagen I content and p38 activation were significantly attenuated. Silencing of CD248 in VSMCs downregulated mitogen-activated protein kinase activation and ECM production. Loss of CD248 in VSMCs destabilized the membrane receptors for Ang II and platelet-derived growth factor (PDGF), and the C-terminal cytoplasmic domain of CD248 is apparently involved in this interaction.

Conclusions

The findings reveal that CD248 regulates the stability of the membrane receptors for Ang II and PDGF in VSMCs to transduce signals for collagen production in combating the loss of aortic wall strength during vascular remodelling.

Key points

  • CD248 reduces the occurrence of angiotensin II (Ang II)-induced aortic lesion by facilitating collagen production to provide load-bearing properties to the aortic wall.
  • CD248 regulates the stability of the membrane receptors for Ang II and PDGF in VSMCs.
  • The C-terminal cytoplasmic tail of CD248 is a crucial domain that potentially regulates the stability of Ang II and PDGF receptors.
  • This knowledge can enhance our understanding of how abdominal aortic aneurysm (AAA) can be treated through CD248-mediated signaling to maintain aortic wall strength during the remodeling process.
CD248缺乏通过降低平滑肌细胞受体稳定性促进血管紧张素ii诱导的主动脉病变
背景腹主动脉瘤(AAA)以腹主动脉进行性扩张为特征,因主动脉破裂导致死亡的发生率很高。AAA的标志是主动脉介质严重退化,并伴有血管平滑肌细胞(VSMCs)的丧失,血管平滑肌细胞是细胞外基质(ECM)蛋白的主要来源。CD248最初与血管生成和肿瘤发生有关,但其在AAA发展中的作用尚不清楚。方法生成缺乏CD248 (CD248−/−)的小鼠,并评估其血管紧张素II (Ang II)和高胆固醇饮食喂养诱导的AAA,采用A7r5和C3H10T1/2细胞功能丧失方法研究CD248在Ang II信号传导中的作用。结果CD248在主动脉瘤患者和小鼠的中膜和外膜中表达上调。小鼠CD248缺乏加剧了angii诱导的主动脉病变,并伴有弹性纤维和VSMC层的严重破坏。有趣的是,虽然在Cd248−/−小鼠的主动脉病变中发现代偿性ECM沉积,但胶原I含量和p38激活显著减弱。VSMCs中CD248的沉默下调了丝裂原活化蛋白激酶的激活和ECM的产生。VSMCs中CD248的缺失破坏了Ang II和血小板衍生生长因子(PDGF)的膜受体的稳定,CD248的c端胞质结构域显然参与了这种相互作用。研究结果表明,CD248调节VSMCs中Ang II和PDGF膜受体的稳定性,在血管重构过程中传递胶原生成的信号,以对抗主动脉壁强度的丧失。CD248通过促进胶原蛋白的生成,为主动脉壁提供承载特性,从而减少血管紧张素II (Ang II)诱导的主动脉病变的发生。CD248调节VSMCs中Ang II和PDGF膜受体的稳定性。CD248的c端细胞质尾部是一个重要的结构域,可能调节Ang II和PDGF受体的稳定性。这一知识可以增强我们对腹主动脉瘤(AAA)如何通过cd248介导的信号传导在重塑过程中维持主动脉壁强度的理解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
15.90
自引率
1.90%
发文量
450
审稿时长
4 weeks
期刊介绍: Clinical and Translational Medicine (CTM) is an international, peer-reviewed, open-access journal dedicated to accelerating the translation of preclinical research into clinical applications and fostering communication between basic and clinical scientists. It highlights the clinical potential and application of various fields including biotechnologies, biomaterials, bioengineering, biomarkers, molecular medicine, omics science, bioinformatics, immunology, molecular imaging, drug discovery, regulation, and health policy. With a focus on the bench-to-bedside approach, CTM prioritizes studies and clinical observations that generate hypotheses relevant to patients and diseases, guiding investigations in cellular and molecular medicine. The journal encourages submissions from clinicians, researchers, policymakers, and industry professionals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信